Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Björn Dahlbäck

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Physiology

Anatomy

Thrombosis

Concepts & Ideas

Phenomena

Protein Binding

Genes & Molecular Sequences

Amino Acid Sequence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
36
Villoutreix, Bruno
28
Zöller, Bengt
23
Hillarp, Andreas
20
García de Frutos, Pablo
16
Blom, Anna
14
Nicolaes, Gerry
14
Shen, Lei
11
Svensson, Peter
9
Steen, Mårten
9
Hafizi, Sassan
8
Härdig, Y
8
Yamazaki, Tomio
7
Norstrøm, Eva
7
Lindqvist, Pelle
7
Malm, Johan

Sign-in to see all Coauthors

Publications

TOP 3
Sevvana Madhumati; Ahnström Josefin; Egerer-Sieber Claudia; Lange Harald A; Dahlbäck Björn; Muller Yves A
Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.
Plomgaard P; Dullaart R P F; de Vries R; Groen A K; Dahlbäck B; Nielsen L B
Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Gustafsson Anna; Martuszewska Danuta; Johansson Martin; Ekman Carl; Hafizi Sassan; Ljungberg Börje; Dahlbäck Björn
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Björn Dahlbäck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sevvana Madhumati; Ahnström Josefin; Egerer-Sieber Claudia; Lange Harald A; Dahlbäck Björn; Muller Yves A
Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.
Journal of molecular biology 2009;393(4):920-36.
2009: Plomgaard P; Dullaart R P F; de Vries R; Groen A K; Dahlbäck B; Nielsen L B
Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Journal of internal medicine 2009;266(3):258-67.
2009: Gustafsson Anna; Martuszewska Danuta; Johansson Martin; Ekman Carl; Hafizi Sassan; Ljungberg Börje; Dahlbäck Björn
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4742-9.
2009: Hellstrand Erik; Lynch Iseult; Andersson Astra; Drakenberg Torbjörn; Dahlbäck Björn; Dawson Kenneth A; Linse Sara; Cedervall Tommy
Complete high-density lipoproteins in nanoparticle corona.
The FEBS journal 2009;276(12):3372-81.
2009: Nielsen Lars B; Christoffersen Christina; Ahnström Josefin; Dahlbäck Björn
ApoM: gene regulation and effects on HDL metabolism.
Trends in endocrinology and metabolism: TEM 2009;20(2):66-71.
2009: Dahlbäck B; Nielsen L B
Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?
Cellular and molecular life sciences : CMLS 2009;66(4):559-64.
2009: Oslakovic Cecilia; Krisinger Michael J; Andersson Astra; Jauhiainen Matti; Ehnholm Christian; Dahlbäck Björn
Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins.
The Journal of biological chemistry 2009;284(9):5896-904.
2009: Gustafsson Anna; Boström Anna-Karin; Ljungberg Börje; Axelson Håkan; Dahlbäck Björn
Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
PloS one 2009;4(10):e7575.
2009: Martuszewska Danuta; Ljungberg Börje; Johansson Martin; Landberg Göran; Oslakovic Cecilia; Dahlbäck Björn; Hafizi Sassan
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.
PloS one 2009;4(2):e4350.
2008: Nielsen Lars Bo; Dahlbäck Björn
Lipid metabolism: why is apoM an apolipoprotein?
Current opinion in lipidology 2008;19(6):622-3.
2008: Ahnström Josefin; Axler Olof; Jauhiainen Matti; Salomaa Veikko; Havulinna Aki S; Ehnholm Christian; Frikke-Schmidt Ruth; Tybjaerg-Hansen Anne; Dahlbäck Björn
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.
Journal of lipid research 2008;49(9):1912-7.
2008: Segers Kenneth; Dahlbäck Björn; Rosing Jan; Nicolaes Gerry A F
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
The Journal of biological chemistry 2008;283(33):22573-81.
2008: Dahlbäck Björn
Advances in understanding pathogenic mechanisms of thrombophilic disorders.
Blood 2008;112(1):19-27.
2008: Steen Mårten; Tran Sinh; Autin Ludovic; Villoutreix Bruno O; Tholander Ann-Louise; Dahlbäck Björn
Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis.
The Journal of biological chemistry 2008;283(30):20805-12.
2008: Christoffersen Christina; Ahnström Josefin; Axler Olof; Christensen Erik Ilsø; Dahlbäck Björn; Nielsen Lars Bo
The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
The Journal of biological chemistry 2008;283(27):18765-72.
2008: Tjwa Marc; Bellido-Martin Lola; Lin Yuan; Lutgens Esther; Plaisance Stéphane; Bono Françoise; Delesque-Touchard Nathalie; Hervé Caroline; Moura Rute; Billiau An D; Aparicio Cristina; Levi Marcel; Daemen Mat; Dewerchin Mieke; Lupu Florea; Arnout Jef; Herbert Jean-Marc; Waer Mark; García de Frutos Pablo; Dahlbäck Björn; Carmeliet Peter; Hoylaerts Marc F; Moons Lieve
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes.
Blood 2008;111(8):4096-105.
2008: Axler Olof; Ahnström Josefin; Dahlbäck Björn
Apolipoprotein M associates to lipoproteins through its retained signal peptide.
FEBS letters 2008;582(5):826-8.
2008: Tran Sinh; Norstrøm Eva; Dahlbäck Björn
Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
The Journal of biological chemistry 2008;283(11):6648-55.
2008: Maurissen Lisbeth F A; Thomassen M Christella L G D; Nicolaes Gerry A F; Dahlbäck Björn; Tans Guido; Rosing Jan; Hackeng Tilman M
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation.
Blood 2008;111(6):3034-41.
2008: Christoffersen Christina; Jauhiainen Matti; Moser Markus; Porse Bo; Ehnholm Christian; Boesl Michael; Dahlbäck Björn; Nielsen Lars Bo
Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
The Journal of biological chemistry 2008;283(4):1839-47.
2008: Malm Karl; Arnljots Björn; Dahlbäck Björn
Human activated protein C variants in a rat model of arterial thrombosis.
Thrombosis journal 2008;6():16.
2008: Lindqvist Pelle G; Dahlbäck Björn
Carriership of Factor V Leiden and evolutionary selection advantage.
Current medicinal chemistry 2008;15(15):1541-4.
2007: Segers Kenneth; Dahlbäck Björn; Bock Paul E; Tans Guido; Rosing Jan; Nicolaes Gerry A F
The role of thrombin exosites I and II in the activation of human coagulation factor V.
The Journal of biological chemistry 2007;282(47):33915-24.
2007: Segers Kenneth; Dahlbäck Björn; Nicolaes Gerry A F
Coagulation factor V and thrombophilia: background and mechanisms.
Thrombosis and haemostasis 2007;98(3):530-42.
2007: Trouw Leendert A; Bengtsson Anders A; Gelderman Kyra A; Dahlbäck Björn; Sturfelt Gunnar; Blom Anna M
C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.
The Journal of biological chemistry 2007;282(39):28540-8.
2007: Axler Olof; Ahnström Josefin; Dahlbäck Björn
An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma.
Journal of lipid research 2007;48(8):1772-80.
2007: Ahnström Josefin; Faber Kirsten; Axler Olof; Dahlbäck Björn
Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M.
Journal of lipid research 2007;48(8):1754-62.
2007: Dahlbäck Björn
The tale of protein S and C4b-binding protein, a story of affection.
Thrombosis and haemostasis 2007;98(1):90-6.
2007: Malm Karl; Arnljots Björn; Persson Ing-Marie; Dahlbäck Björn
Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.
Thrombosis research 2007;120(4):531-9.
2006: Hafizi Sassan; Dahlbäck Björn
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.
The FEBS journal 2006;273(23):5231-44.
2006: Norstrøm Eva A; Tran Sinh; Steen Mårten; Dahlbäck Björn
Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.
The Journal of biological chemistry 2006;281(42):31486-94.
2006: Preston Roger J S; Ajzner Eva; Razzari Cristina; Karageorgi Stalo; Dua Sonia; Dahlbäck Björn; Lane David A
Multifunctional specificity of the protein C/activated protein C Gla domain.
The Journal of biological chemistry 2006;281(39):28850-7.
2006: Hafizi Sassan; Dahlbäck Björn
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
Cytokine & growth factor reviews 2006;17(4):295-304.
2006: Christoffersen Christina; Nielsen Lars Bo; Axler Olof; Andersson Astra; Johnsen Anders H; Dahlbäck Björn
Isolation and characterization of human apolipoprotein M-containing lipoproteins.
Journal of lipid research 2006;47(8):1833-43.
2006: Dahlbäck Björn; Nielsen Lars B
Apolipoprotein M--a novel player in high-density lipoprotein metabolism and atherosclerosis.
Current opinion in lipidology 2006;17(3):291-5.
2006: Autin Ludovic; Steen Mårten; Dahlbäck Björn; Villoutreix Bruno O
Proposed structural models of the prothrombinase (FXa-FVa) complex.
Proteins 2006;63(3):440-50.
2006: Faber Kirsten; Hvidberg Vibeke; Moestrup Søren K; Dahlbäck Björn; Nielsen Lars Bo
Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M.
Molecular endocrinology (Baltimore, Md.) 2006;20(1):212-8.
2006: Christoffersen C; Dahlbäck B; Nielsen L B
Apolipoprotein M: progress in understanding its regulation and metabolic functions.
Scandinavian journal of clinical and laboratory investigation 2006;66(7):631-7.
2005: Johansson Anna M; Hillarp Andreas; Säll Torbjörn; Zöller Bengt; Dahlbäck Björn; Halldén Christer
Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency.
Thrombosis and haemostasis 2005;94(5):951-7.
2005: Hafizi Sassan; Gustafsson Anna; Stenhoff Jonas; Dahlbäck Björn
The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases.
The international journal of biochemistry & cell biology 2005;37(11):2344-56.
2005: Dahlbäck Björn; Villoutreix Bruno O
Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1311-20.
2005: Dahlbäck Björn; Villoutreix Bruno O
The anticoagulant protein C pathway.
FEBS letters 2005;579(15):3310-6.
2005: Hafizi Sassan; Ibraimi Filiz; Dahlbäck Björn
C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(8):971-3.
2005: Balogh Istvan; Hafizi Sassan; Stenhoff Jonas; Hansson Karin; Dahlbäck Björn
Analysis of Gas6 in human platelets and plasma.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1280-6.
2005: Dahlbäck Björn
Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.
Journal of internal medicine 2005;257(3):209-23.
2005: Preston Roger J S; Villegas-Mendez Ana; Sun Yong-Hui; Hermida José; Simioni Paolo; Philippou Helen; Dahlbäck Björn; Lane David A
Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation.
The FEBS journal 2005;272(1):97-108.
2005: Dahlbäck Björn
The importance of the protein C system in the pathogenesis of venous thrombosis.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():138-9.
2004: Lanke E; Johansson A M; Hillarp A; Lethagen S; Zöller B; Dahlbäck B; Halldén C
Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.
Journal of thrombosis and haemostasis : JTH 2004;2(11):1918-23.
2004: Sun Yong-Hui; Tran Sinh; Norstrøm Eva A; Dahlbäck Björn
Enhanced rate of cleavage at Arg-306 and Arg-506 in coagulation factor Va by Gla domain-mutated human-activated protein C.
The Journal of biological chemistry 2004;279(46):47528-35.
2004: Nicolaes Gerry A F; Sørensen Kristoffer W; Friedrich Ute; Tans Guido; Rosing Jan; Autin Ludovic; Dahlbäck Björn; Villoutreix Bruno O
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin.
European journal of biochemistry / FEBS 2004;271(13):2724-36.
2004: Stenhoff Jonas; Dahlbäck Björn; Hafizi Sassan
Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.
Biochemical and biophysical research communications 2004;319(3):871-8.
2004: Faber Kirsten; Axler Olof; Dahlbäck Björn; Nielsen Lars Bo
Characterization of apoM in normal and genetically modified mice.
Journal of lipid research 2004;45(7):1272-8.
2004: Kask Lena; Trouw Leendert A; Dahlbäck Björn; Blom Anna M
The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells.
The Journal of biological chemistry 2004;279(23):23869-73.
2004: Sørensen Kristoffer W; Nicolaes Gerry A F; Villoutreix Bruno O; Yamazaki Tomio; Tans Guido; Rosing Jan; Dahlbäck Björn
Functional properties of recombinant factor V mutated in a potential calcium-binding site.
Biochemistry 2004;43(19):5803-10.
2004: Kask Lena; Villoutreix Bruno O; Steen Mårten; Ramesh Bala; Dahlbäck Björn; Blom Anna M
Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.
Protein science : a publication of the Protein Society 2004;13(5):1356-64.
2004: Steen Mårten; Norstrøm Eva A; Tholander Ann-Louise; Bolton-Maggs Paula H B; Mumford Andrew; McVey John H; Tuddenham Edward G D; Dahlbäck Björn
Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
Blood 2004;103(9):3381-7.
2004: Blom Anna M; Villoutreix Bruno O; Dahlbäck Björn
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
Molecular immunology 2004;40(18):1333-46.
2004: Blom Anna M; Villoutreix Bruno O; Dahlbäck Björn
Functions of human complement inhibitor C4b-binding protein in relation to its structure.
Archivum immunologiae et therapiae experimentalis 2004;52(2):83-95.
2004: Dahlbäck Björn
Progress in the understanding of the protein C anticoagulant pathway.
International journal of hematology 2004;79(2):109-16.
2004: Heiring Christoph; Dahlbäck Björn; Muller Yves A
Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family.
The Journal of biological chemistry 2004;279(8):6952-8.
2003: Blom Anna M; Villoutreix Bruno O; Dahlbäck Björn
Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.
The Journal of biological chemistry 2003;278(44):43437-42.
2003: Malm Karl; Dahlbäck Björn; Arnljots Björn
Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S.
Thrombosis and haemostasis 2003;90(2):227-34.
2003: Steen Marten; Miteva Maria; Villoutreix Bruno O; Yamazaki Tomio; Dahlbäck Björn
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
Blood 2003;102(4):1316-22.
2003: Dahlbäck B; Villoutreix B O
Molecular recognition in the protein C anticoagulant pathway.
Journal of thrombosis and haemostasis : JTH 2003;1(7):1525-34.
2003: Norstrøm Eva A; Steen Mårten; Tran Sinh; Dahlbäck Björn
Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
The Journal of biological chemistry 2003;278(27):24904-11.
2003: Webb Joanna H; Blom Anna M; Dahlbäck Björn
The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):355-9.
2003: Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Journal of thrombosis and haemostasis : JTH 2003;1(5):943-9.
2003: Lindqvist Pelle G; Dahlbäck Björn
Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women.
Acta obstetricia et gynecologica Scandinavica 2003;82(5):467-70.
2003: Procházka Martin; Happach Catharina; Marsál Karel; Dahlbäck Björn; Lindqvist Pelle G
Factor V Leiden in pregnancies complicated by placental abruption.
BJOG : an international journal of obstetrics and gynaecology 2003;110(5):462-6.
2003: Malm Karl; Dahlbäck Björn; Arnljots Björn
Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
Plastic and reconstructive surgery 2003;111(5):1659-66.
2003: Dahlbäck Björn
Successful hunt for quantitative trait locus in thrombophilia.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(3):376-7.
2003: Sun Yong-Hui; Shen Lei; Dahlbäck Björn
Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding.
Blood 2003;101(6):2277-84.
2003: Nicolaes Gerry A F; Dahlbäck Björn
Congenital and acquired activated protein C resistance.
Seminars in vascular medicine 2003;3(1):33-46.
2003: Nicolaes Gerry A F; Dahlbäck Björn
Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.
Hematology/oncology clinics of North America 2003;17(1):37-61, vi.
2003: Dahlbäck B
The discovery of activated protein C resistance.
Journal of thrombosis and haemostasis : JTH 2003;1(1):3-9.
2003: Webb Joanna H; Villoutreix Bruno O; Dahlbäck Björn; Blom Anna M
Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies.
European journal of biochemistry / FEBS 2003;270(1):93-100.
2003: Blom Anna M; Kask Lena; Dahlbäck Björn
CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Molecular immunology 2003;39(10):547-56.
2003: Persson Kristina E M; Dahlbäck Björn; Hillarp Andreas
Diagnosing protein S deficiency: analytical considerations.
Clinical laboratory 2003;49(3-4):103-10.
2002: Serra Josep; Sales Miquel; Chitolie Andrew; Domènech Pere; Rossi Edoardo; Borrell Montserrat; Dahlbäck Björn
Multicentre evaluation of IL Test Free PS: a fully automated assay to quantify free protein S.
Thrombosis and haemostasis 2002;88(6):975-83.
2002: Hafizi Sassan; Alindri Filiz; Karlsson Roger; Dahlbäck Björn
Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.
Biochemical and biophysical research communications 2002;299(5):793-800.
2002: Steen Mårten; Villoutreix Bruno O; Norstrøm Eva A; Yamazaki Tomio; Dahlbäck Björn
Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
The Journal of biological chemistry 2002;277(51):50022-9.
2002: Yamazaki Tomio; Nicolaes Gerry A F; Sørensen Kristoffer W; Dahlbäck Björn
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
Blood 2002;100(7):2515-21.
2002: Steen Mårten; Dahlbäck Björn
Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.
The Journal of biological chemistry 2002;277(41):38424-30.
2002: Webb Joanna H; Blom Anna M; Dahlbäck Björn
Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2580-6.
2002: Lindqvist Pelle G; Olofsson Per; Dahlbäck Björn
Use of selective factor V Leiden screening in pregnancy to identify candidates for anticoagulants.
Obstetrics and gynecology 2002;100(2):332-6.
2002: Kask Lena; Hillarp Andreas; Ramesh Bala; Dahlbäck Björn; Blom Anna M
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein.
Biochemistry 2002;41(30):9349-57.
2002: Norstrøm Eva; Thorelli Elisabeth; Dahlbäck Björn
Functional characterization of recombinant FV Hong Kong and FV Cambridge.
Blood 2002;100(2):524-30.
2002: Lindqvist Pelle G; Kublikas Marius; Dahlbäck Björn
Individual risk assessment of thrombosis in pregnancy.
Acta obstetricia et gynecologica Scandinavica 2002;81(5):412-6.
2002: Nicolaes Gerry A F; Dahlbäck Björn
Factor V and thrombotic disease: description of a janus-faced protein.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(4):530-8.
2002: Giri Tusar Kanti; Linse Sara; García de Frutos Pablo; Yamazaki Tomio; Villoutreix Bruno O; Dahlbäck Björn
Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein.
The Journal of biological chemistry 2002;277(17):15099-106.
2002: Yamazaki Tomio; Saito Hidehiko; Dahlbäck Björn
Rapid intracellular degradation of a truncated mutant protein S (Q522X).
Thrombosis and haemostasis 2002;87(1):171-2.
2001: Persson K E; Hillarp A; Dahlbäck B
Analytical considerations for free protein S assays in protein S deficiency.
Thrombosis and haemostasis 2001;86(5):1144-7.
2001: Blom A M; Kask L; Dahlbäck B
Structural requirements for the complement regulatory activities of C4BP.
The Journal of biological chemistry 2001;276(29):27136-44.
2001: Friedrich U; Blom A M; Dahlbäck B; Villoutreix B O
Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.
The Journal of biological chemistry 2001;276(26):24122-8.
2001: Friedrich U; Nicolaes G A; Villoutreix B O; Dahlbäck B
Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va.
The Journal of biological chemistry 2001;276(25):23105-8.
2001: Villoutreix B O; Dahlbäck B; Borgel D; Gandrille S; Muller Y A
Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights.
Proteins 2001;43(2):203-16.
2000: Giri T K; García de Frutos P; Dahlbäck B
Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised.
Thrombosis and haemostasis 2000;84(3):413-9.
2000: Evenäs P; García de Frutos P; Nicolaes G A; Dahlbäck B
The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Thrombosis and haemostasis 2000;84(2):271-7.
2000: Giri T K; Yamazaki T; Sala N; Dahlbäck B; de Frutos P G
Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors.
Blood 2000;96(2):523-31.
2000: Dahlbäck B
Blood coagulation.
Lancet 2000;355(9215):1627-32.
2000: Blom A M; Berggârd K; Webb J H; Lindahl G; Villoutreix B O; Dahlbäck B
Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(10):5328-36.
2000: Ekberg H; Svensson P J; Simanaitis M; Dahlbäck B
Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection.
Transplantation 2000;69(8):1577-81.
2000: Evenäs P; Dahlbäck B; García de Frutos P
The first laminin G-type domain in the SHBG-like region of protein S contains residues essential for activation of the receptor tyrosine kinase sky.
Biological chemistry 2000;381(3):199-209.
2000: Shen L; Dahlbäck B; Villoutreix B O
Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
Biochemistry 2000;39(11):2853-60.
2000: Nicolaes G A; Villoutreix B O; Dahlbäck B
Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(1):89-100.
2000: Espinosa-Parrilla Y; Yamazaki T; Sala N; Dahlbäck B; de Frutos P G
Protein S secretion differences of missense mutants account for phenotypic heterogeneity.
Blood 2000;95(1):173-9.
1999: Giri T K; de Frutos P G; Yamazaki T; Villoutreix B O; Dahlbäck B
In vitro characterisation of two naturally occurring mutations in the thrombin-sensitive region of anticoagulant protein S.
Thrombosis and haemostasis 1999;82(6):1627-33.
1999: Evenäs P; García De Frutos P; Linse S; Dahlbäck B
Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein.
European journal of biochemistry / FEBS 1999;266(3):935-42.
1999: Villoutreix B O; Blom A M; Dahlbäck B
Structural prediction and analysis of endothelial cell protein C/activated protein C receptor.
Protein engineering 1999;12(10):833-40.
1999: Xu N; Dahlbäck B
A novel human apolipoprotein (apoM).
The Journal of biological chemistry 1999;274(44):31286-90.
1999: Nicolaes G A; Villoutreix B O; Dahlbäck B
Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation.
Biochemistry 1999;38(41):13584-91.
1999: Shen L; Villoutreix B O; Dahlbäck B
Interspecies loop grafting in the protease domain of human protein C yielding enhanced catalytic and anticoagulant activity.
Thrombosis and haemostasis 1999;82(3):1078-87.
1999: Shen L; Villoutreix B O; Dahlbäck B
Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
Thrombosis and haemostasis 1999;82(1):72-9.
1999: Blom A M; Webb J; Villoutreix B O; Dahlbäck B
A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function.
The Journal of biological chemistry 1999;274(27):19237-45.
1999: Holm J; Hillarp A; Zöller B; Erhardt L; Berntorp E; Dahlbäck B
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome.
Thrombosis and haemostasis 1999;81(6):857-60.
1999: Villoutreix B O; Blom A M; Webb J; Dahlbäck B
The complement regulator C4b-binding protein analyzed by molecular modeling, bioinformatics and computer-aided experimental design.
Immunopharmacology 1999;42(1-3):121-34.
1999: Dahlbäck B
Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms.
The Journal of laboratory and clinical medicine 1999;133(5):415-22.
1999: Knobe K E; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix B O
Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
Proteins 1999;35(2):218-34.
1999: Lindqvist P G; Svensson P J; Marsaál K; Grennert L; Luterkort M; Dahlbäck B
Activated protein C resistance (FV:Q506) and pregnancy.
Thrombosis and haemostasis 1999;81(4):532-7.
1999: Thorelli E; Kaufman R J; Dahlbäck B
Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
Blood 1999;93(8):2552-8.
1999: Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Thrombophilia as a multigenic disease.
Haematologica 1999;84(1):59-70.
1999: Dahlbäck B
Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Seminars in thrombosis and hemostasis 1999;25(3):273-89.
1998: Giri T K; Villoutreix B O; Wallqvist A; Dahlbäck B; de Frutos P G
Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling.
Thrombosis and haemostasis 1998;80(5):798-804.
1998: Shen L; Shah A M; Dahlbäck B; Nelsestuen G L
Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain.
The Journal of biological chemistry 1998;273(47):31086-91.
1998: Sampram E S; Lindblad B; Dahlbäck B
Activated protein C resistance in patients with peripheral vascular disease.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 1998;28(4):624-9.
1998: Blom A M; Covell D G; Wallqvist A; Dahlbäck B; Villoutreix B O
The C4b-binding protein-protein S interaction is hydrophobic in nature.
Biochimica et biophysica acta 1998;1388(1):181-9.
1998: He X; Shen L; Villoutreix B O; Dahlbäck B
Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function.
The Journal of biological chemistry 1998;273(42):27449-58.
1998: Nyberg P; Dahlbäck B; García de Frutos P
The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.
FEBS letters 1998;433(1-2):28-32.
1998: Thorelli E; Kaufman R J; Dahlbäck B
Cleavage requirements of factor V in tissue-factor induced thrombin generation.
Thrombosis and haemostasis 1998;80(1):92-8.
1998: Villoutreix B O; Dahlbäck B
Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
Protein science : a publication of the Protein Society 1998;7(6):1317-25.
1998: Thorelli E; Kaufman R J; Dahlbäck B
The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
The Journal of biological chemistry 1998;273(26):16140-5.
1998: Villoutreix B O; Härdig Y; Wallqvist A; Covell D G; García de Frutos P; Dahlbäck B
Structural investigation of C4b-binding protein by molecular modeling: localization of putative binding sites.
Proteins 1998;31(4):391-405.
1998: Zöller B; García de Frutos P; Dahlbäck B
A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
Thrombosis and haemostasis 1998;79(4):802-7.
1998: Giri T K; Hillarp A; Härdig Y; Zöller B; Dahlbäck B
A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen.
Thrombosis and haemostasis 1998;79(4):767-72.
1998: Stenberg Y; Drakenberg T; Dahlbäck B; Stenflo J
Characterization of recombinant epidermal growth factor (EGF)-like modules from vitamin-K-dependent protein S expressed in Spodoptera cells--the cofactor activity depends on the N-terminal EGF module in human protein S.
European journal of biochemistry / FEBS 1998;251(3):558-64.
1998: Lindqvist P G; Svensson P J; Dahlbäck B; Marsál K
Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism.
Thrombosis and haemostasis 1998;79(1):69-73.
1998: Xu N; Dahlbäck B; Ohlin A K; Nilsson A
Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(1):33-9.
1998: Simmonds R E; Ireland H; Lane D A; Zöller B; García de Frutos P; Dahlbäck B
Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect.
Annals of internal medicine 1998;128(1):8-14.
1997: Shen L; Shah A M; Dahlbäck B; Nelsestuen G L
Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10.
Biochemistry 1997;36(51):16025-31.
1997: Villoutreix B O; García de Frutos P; Lövenklev M; Linse S; Fernlund P; Dahlbäck B
SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations.
Proteins 1997;29(4):478-91.
1997: Shen L; He X; Dahlbäck B
Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
Thrombosis and haemostasis 1997;78(3):1030-6.
1997: Svensson P J; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
Thrombosis and haemostasis 1997;78(3):993-6.
1997: Hillarp A; Zöller B; Svensson P J; Dahlbäck B
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.
Thrombosis and haemostasis 1997;78(3):990-2.
1997: Thorelli E; Kaufman R J; Dahlbäck B
Cleavage requirements for activation of factor V by factor Xa.
European journal of biochemistry / FEBS 1997;247(1):12-20.
1997: Dahlbäck B
Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Seminars in hematology 1997;34(3):217-34.
1997: Dahlbäck B
Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
Thrombosis and haemostasis 1997;78(1):483-8.
1997: Simmonds R E; Zöller B; Ireland H; Thompson E; de Frutos P G; Dahlbäck B; Lane D A
Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes.
Blood 1997;89(12):4364-70.
1997: Dahlbäck B
Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1997;49 Suppl 1():3-5.
1997: Villoutreix B O; Teleman O; Dahlbäck B
A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity.
Journal of computer-aided molecular design 1997;11(3):293-304.
1997: Svensson P J; Zöller B; Mattiasson I; Dahlbäck B
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis.
Journal of internal medicine 1997;241(5):379-85.
1997: Härdig Y; Hillarp A; Dahlbäck B
The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.
The Biochemical journal 1997;323 ( Pt 2)():469-75.
1997: Svensson P J; Zöller B; Dahlbäck B
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
Thrombosis and haemostasis 1997;77(2):332-5.
1997: Zöller B; Hillarp A; Dahlbäck B
Activated protein C resistance caused by a common factor V mutation has a single origin.
Thrombosis research 1997;85(3):237-43.
1997: Hillarp A; Wiklund H; Thern A; Dahlbäck B
Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1315-23.
1997: Dahlbäck B
Factor V and protein S as cofactors to activated protein C.
Haematologica 1997;82(1):91-5.
1997: Zöller B; Hillarp A; Berntorp E; Dahlbäck B
Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
Annual review of medicine 1997;48():45-58.
1996: Bengtsson A; Zöller B; de Frutos P G; Dahlbäck B; Sturfelt G
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus.
Lupus 1996;5(6):598-601.
1996: Hillarp A; Zöller B; Dahlbäck B
Activated protein C resistance as a basis for venous thrombosis.
The American journal of medicine 1996;101(5):534-40.
1996: Dahlbäck B; Zöller B; Hillarp A
Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
Haemostasis 1996;26 Suppl 4():301-14.
1996: Härdig Y; Dahlbäck B
The amino-terminal module of the C4b-binding protein beta-chain contains the protein S-binding site.
The Journal of biological chemistry 1996;271(34):20861-7.
1996: Dahlbäck B
Are we ready for factor V Leiden screening?
Lancet 1996;347(9012):1346-7.
1996: Dahlbäck B; Hillarp A; Rosen S; Zöller B
Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis.
Annals of hematology 1996;72(4):166-76.
1996: Holm J; Zöller B; Berntorp E; Erhardt L; Dahlbäck B
Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries.
Journal of internal medicine 1996;239(3):221-6.
1996: Zöller B; Holm J; Svensson P; Dahlbäck B
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Thrombosis and haemostasis 1996;75(2):270-4.
1996: Aparicio C; Dahlbäck B
Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
The Biochemical journal 1996;313 ( Pt 2)():467-72.
1995: Hillarp A; Dahlbäck B; Zöller B
Activated protein C resistance: from phenotype to genotype and clinical practice.
Blood reviews 1995;9(4):201-12.
1995: García de Frutos P; Härdig Y; Dahlbäck B
Serum amyloid P component binding to C4b-binding protein.
The Journal of biological chemistry 1995;270(45):26950-5.
1995: Janciauskiene S; García de Frutos P; Carlemalm E; Dahlbäck B; Eriksson S
Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component.
The Journal of biological chemistry 1995;270(44):26041-4.
1995: Dahlbäck B
[A test for APC resistance prior to prescription of oral contraceptives? Discussion about screening should be based on facts]
Läkartidningen 1995;92(48):4558, 4561.
1995: Zöller B; Dahlbäck B
Resistance to activated protein C caused by a factor V gene mutation.
Current opinion in hematology 1995;2(5):358-64.
1995: Dahlbäck B
New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
Thrombosis and haemostasis 1995;74(1):139-48.
1995: Arnljots B; Dahlbäck B
Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(7):937-41.
1995: Härdig Y; García de Frutos P; Dahlbäck B
Expression and characterization of a recombinant C4b-binding protein lacking the beta-chain.
The Biochemical journal 1995;308 ( Pt 3)():795-800.
1995: Zöller B; García de Frutos P; Dahlbäck B
Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease.
Blood 1995;85(12):3524-31.
1995: Zöller B; Berntsdotter A; García de Frutos P; Dahlbäck B
Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.
Blood 1995;85(12):3518-23.
1995: He X; Shen L; Bjartell A; Malm J; Lilja H; Dahlbäck B
The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1995;43(6):563-70.
1995: Dahlbäck B
Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
The Journal of laboratory and clinical medicine 1995;125(5):566-71.
1995: Arnljots B; Dahlbäck B
Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.
The Journal of clinical investigation 1995;95(5):1987-93.
1995: Zöller B; He X; Dahlbäck B
Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
Thrombosis and haemostasis 1995;73(5):743-5.
1995: Dahlbäck B
Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
Thrombosis and haemostasis 1995;73(5):739-42.
1995: García de Frutos P; Dahlbäck B
cDNA structure of rabbit C4b-binding protein alpha-chain. Preserved sequence motive in complement regulatory protein modules which bind C4b.
Biochimica et biophysica acta 1995;1261(2):285-9.
1995: Dahlbäck B
Molecular genetics of venous thromboembolism.
Annals of medicine 1995;27(2):187-92.
1995: Dahlbäck B
Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism.
Journal of internal medicine 1995;237(3):221-7.
1995: Dahlbäck B
Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.
Haematologica 1995;80(2 Suppl):102-13.
1995: Dahlbäck B
Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism.
Blood 1995;85(3):607-14.
1995: He X; Shen L; Dahlbäck B
Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity.
European journal of biochemistry / FEBS 1995;227(1-2):433-40.
1995: He X; Shen L; Bjartell A; Dahlbäck B
The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit organs as demonstrated by northern blotting, in situ hybridization, and immunohistochemistry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1995;43(1):85-96.
1995: Dahlbäck B
The protein C anticoagulant system: inherited defects as basis for venous thrombosis.
Thrombosis research 1995;77(1):1-43.
1995: Dahlbäck B
Thrombophilia: the discovery of activated protein C resistance.
Advances in genetics 1995;33():135-75.
1994: Zöller B; Svensson P J; He X; Dahlbäck B
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
The Journal of clinical investigation 1994;94(6):2521-4.
1994: Hillarp A; Thern A; Dahlbäck B
Bovine C4b binding protein. Molecular cloning of the alpha- and beta-chains provides structural background for lack of complex formation with protein S.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(9):4190-9.
1994: Holm J; Zöller B; Svensson P J; Berntorp E; Erhardt L; Dahlbäck B
Myocardial infarction associated with homozygous resistance to activated protein C.
Lancet 1994;344(8927):952-3.
1994: Dahlbäck B
Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.
The Journal of clinical investigation 1994;94(3):923-7.
1994: Malm J; He X H; Bjartell A; Shen L; Abrahamsson P A; Dahlbäck B
Vitamin K-dependent protein S in Leydig cells of human testis.
The Biochemical journal 1994;302 ( Pt 3)():845-50.
1994: Arnljots B; Bergqvist D; Dahlbäck B
Inhibition of microarterial thrombosis by activated protein C in a rabbit model.
Thrombosis and haemostasis 1994;72(3):415-20.
1994: García de Frutos P; Alim R I; Härdig Y; Zöller B; Dahlbäck B
Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S.
Blood 1994;84(3):815-22.
1994: Shen L; Dahlbäck B
Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.
The Journal of biological chemistry 1994;269(29):18735-8.
1994: Zöller B; Dahlbäck B
Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
Lancet 1994;343(8912):1536-8.
1994: He X; Dahlbäck B
Rabbit plasma, unlike its human counterpart, contains no complex between protein S and C4b-binding protein.
Thrombosis and haemostasis 1994;71(4):446-51.
1994: García de Frutos P; Dahlbäck B
Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2430-7.
1994: Dahlbäck B
Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
Haemostasis 1994;24(2):139-51.
1994: Svensson P J; Dahlbäck B
Resistance to activated protein C as a basis for venous thrombosis.
The New England journal of medicine 1994;330(8):517-22.
1994: Dahlbäck B; Hildebrand B
Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(4):1396-400.
1993: He X; Dahlbäck B
Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S.
European journal of biochemistry / FEBS 1993;217(3):857-65.
1993: Donnér M; Kristoffersson A C; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson I M; Holmberg L
Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
European journal of haematology 1993;51(1):38-44.
1993: Hillarp A; Pardo-Manuel F; Ruiz R R; Rodriguez de Cordoba S; Dahlbäck B
The human C4b-binding protein beta-chain gene.
The Journal of biological chemistry 1993;268(20):15017-23.
1993: Dahlbäck B; Carlsson M; Svensson P J
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(3):1004-8.
1993: Härdig Y; Rezaie A; Dahlbäck B
High affinity binding of human vitamin K-dependent protein S to a truncated recombinant beta-chain of C4b-binding protein expressed in Escherichia coli.
The Journal of biological chemistry 1993;268(5):3033-6.
1992: Dahlbäck B; Wiedmer T; Sims P J
Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles.
Biochemistry 1992;31(51):12769-77.
1992: Donnér M; Kristoffersson A C; Lenk H; Scheibel E; Dahlbäck B; Nilsson I M; Holmberg L
Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden.
British journal of haematology 1992;82(1):58-65.
1992: Malm J; Laurell M; Nilsson I M; Dahlbäck B
Thromboembolic disease--critical evaluation of laboratory investigation.
Thrombosis and haemostasis 1992;68(1):7-13.
1991: Donnér M; Andersson A M; Kristoffersson A C; Nilsson I M; Dahlbäck B; Holmberg L
An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease.
European journal of haematology 1991;47(5):342-5.
1991: Andersson M; Hanson A; Englund G; Dahlbäck B
Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
European journal of clinical pharmacology 1991;40(3):261-5.
1990: Dahlbäck B; Hildebrand B; Linse S
Novel type of very high affinity calcium-binding sites in beta-hydroxyasparagine-containing epidermal growth factor-like domains in vitamin K-dependent protein S.
The Journal of biological chemistry 1990;265(30):18481-9.
1990: Dahlbäck B; Frohm B; Nelsestuen G
High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Suggestion of a third component in blood regulating the interaction.
The Journal of biological chemistry 1990;265(27):16082-7.
1990: Pardo-Manuel F; Rey-Campos J; Hillarp A; Dahlbäck B; Rodriguez de Cordoba S
Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(12):4529-32.
1990: Dahlbäck B; Hildebrand B; Malm J
Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies.
The Journal of biological chemistry 1990;265(14):8127-35.
1990: Hillarp A; Dahlbäck B
Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(3):1183-7.
1990: Malm J; Cohen E; Dackowski W; Dahlbäck B; Wydro R
Expression of completely gamma-carboxylated and beta-hydroxylated recombinant human vitamin-K-dependent protein S with full biological activity.
European journal of biochemistry / FEBS 1990;187(3):737-43.
1990: Nilsson I M; Berntorp E; Zettervall O; Dahlbäck B
Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients.
Blood 1990;75(2):378-83.
1989: Hillarp A; Hessing M; Dahlbäck B
Protein S binding in relation to the subunit composition of human C4b-binding protein.
FEBS letters 1989;259(1):53-6.
1988: Dahlbäck B; Hansson C; Islam M Q; Szpirer J; Szpirer C; Lundwall A; Levan G
Assignment of gene for coagulation factor V to chromosome 1 in man and to chromosome 13 in rat.
Somatic cell and molecular genetics 1988;14(5):509-14.
1988: Hillarp A; Dahlbäck B
Novel subunit in C4b-binding protein required for protein S binding.
The Journal of biological chemistry 1988;263(25):12759-64.
1988: Malm J; Bennhagen R; Holmberg L; Dahlbäck B
Plasma concentrations of C4b-binding protein and vitamin K-dependent protein S in term and preterm infants: low levels of protein S-C4b-binding protein complexes.
British journal of haematology 1988;68(4):445-9.
1988: Malm J; Laurell M; Dahlbäck B
Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception.
British journal of haematology 1988;68(4):437-43.
1988: Dahlbäck B
A new model for coagulation factor V suggesting a unique mechanism of activation.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1988;191():47-61.
1986: Lundwall A; Dackowski W; Cohen E; Shaffer M; Mahr A; Dahlbäck B; Stenflo J; Wydro R
Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(18):6716-20.

Sign-in to see more